Immunicum AB (publ) Interim Report April - June 2021

What we doOur approachPipelineTechnologyPatient Stories
About usManagementBoardClinical Advisory BoardCareers
NewsroomPress releasesEvents
Investors

Back
Immunicum AB (publ) Interim Report April - June 2021
 8:00:00 AM

Keep reading
Immunicum Receives Advanced Therapy Medicinal Product Classification from the EMA for Cancer Relapse Vaccine Candidate DCP-001Read